Skip to main content

Table 2 Adverse sequelae after 3-day 3-AP then cisplatin (n = 6)

From: Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

Adverse Event Category

0

1

2

3

4

5

Anemia

1

1

4

0

0

0

Leukopenia

1

2

2

1

0

0

Neutropenia

1

1

2

1

1

0

Thrombocytopenia

3

1

2

0

0

0

Allergy/Immunology

5

0

1

0

0

0

Constitutional

2

3

1

0

0

0

Dermatologic

3

1

2

0

0

0

Nausea

3

1

2

0

0

0

Vomiting

3

0

2

1

0

0

Gastrointestinal

3

2

0

1

0

0

Metabolic

3

1

2

0

0

0

Neurosensory

4

2

0

0

0

0

Other Neurological

4

1

1

0

0

0

Pain

5

0

0

1

0

0

Pulmonary

4

0

0

2

0

0